| Dear Voornaam
Would you like to help Black undergrads explore their interest in cancer research? Black in Cancer is calling for hosts for an 8-week summer internship (July September) as part of its 2023 mentorship programme.
The programme provides valuable practical work experience to mentees and helps them to better understand their career options in academic research.
The deadline to apply to be a host is 4 May. For more information or to apply to host a student please contact [email protected]. Applications should include a project title, abstract and brief description of the skills the student will gain. |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
ADVANCE YOUR RESEARCH WITH STATE-OF-THE-ART CRISPR TECHNOLOGY Are you a researcher based in a Cancer Research UK institute or a Cancer Research UK grant holder and want to access our novel CRISPR technology? Then the joint AstraZenecaCancer Research Horizons Functional Genomics Centre (FGC)s open call for proposals may interest you.
The FGC delivers state-of-the-art functional genetic screens, cancer modelling and big data processing all aimed at accelerating the discovery of new cancer medicines.
If you are interested in accessing the FGC's screening capabilities, contact Beatrice Lana for an informal chat about your project ideas. Proposals are reviewed every two months, with the next deadline coming up on 1 May.
|
|
|---|
|
|---|
|
|
NEW COMBINATION THERAPY COULD BENEFIT CHILDREN AND YOUNG PEOPLE WITH CANCER At this years AACR Annual Meeting, Gatz and colleagues presented emerging results from the phase 1 portion of the ESMART trial.
Their results showed a clinical benefit in combining ATR inhibitors with PARP inhibitors in patients with solid tumours that show DNA replication and damage repair deficiencies.
ESMART is a proof-of-concept platform trial that matches children and young adults with relapsed or refractory cancers with personalised therapies based on their genetic profile.
The investigators have so far evaluated 15 different treatments, mostly combination strategies, in more than 220 children and young people following high-throughput genomic profiling of their tumours. |
|
|---|
| PRECISION MEDICINE: THE NEXT WEBINAR FOR CHILDRENS & YOUNG PEOPLES CANCER RESEARCH Next in the research events series for childrens and young peoples cancer will be a webinar exploring precision medicine.
Join the conversation and hear insights from experts in precision medicine and childrens and young peoples cancer on using data, tools and techniques to diagnose, treat and monitor patients.
The webinar will take place on 5 July 2023, at 45:30pm BST. |
|
|---|
|
|---|
|
|
MEET THE SPEAKERS FOR OUR RADIATION RESEARCH CONFERENCE The latest speakers to be confirmed for our international radiation research event are: Karl Butterworth (Queens University Belfast) keynote Marie Catherine Vozenin (Swiss Cancer Center) plenary Hilary Stobart, Helen Bulbeck and Richard Stephens patient advocates Silvia Formenti (Weill Cornell Medical College Immunology) immunology panel Jamie Dean (City of London) and Philippe Lambin (Maastricht University) AI and computational modelling panelJoin us on 46 June for an agenda packed with presentations, discussions and networking with global experts and patient advocates. |
|
|---|
|
|---|
|
|
HORIZON EUROPE PLAN B ANNOUNCED Just before Easter, the UK government published its new plan Pioneer to provide an alternative to Horizon Europe funding if forming an association with the funding programme is not possible.
The Pioneer scheme promises to cover the full 14.6bn that would have gone into Horizon Europe and would allow continued collaboration through Third Country Participation until March 2025.
Its promising to see the government engaging with the UK research community to develop contingency plans, but we continue to support Horizon Europe association as the best possible outcome for global cancer research. |
|
|---|
| NEW COLLABORATION WITH PATIENT ADVOCACY GROUP USE MY DATA Were funding use MY data to help it expand its work around awareness, trust and support for the use of patient data in research.
Patient data can be used to gain insights and save lives, but needs to be used efficiently and transparently to have the greatest impact.
Were working together with use MY data to build a stronger, more united voice around the use of patient data and drive forward best practice for public involvement and engagement with data research. |
|
|---|
|
|---|
|
|
ACCESS 15M SEED FUNDING TO SPIN OUT YOUR RESEARCH The Cancer Research Horizons Seed Fund provides the funding and expert support you need to take your innovative cancer research from bench to bedside.
Cancer Research Horizons, our innovation engine, has over 25 years experience establishing and growing over 60 startup companies, which have gone on to raise 2.3bn+ in investment. If you would like to join this cohort get in touch with the Cancer Research Horizons team. |
|
|---|
|
|---|
|
|
UPDATES TO YOUR GRANT CONDITIONS AND FUNDING POLICIES Weve updated our standard grant conditions, data sharing and management policy and policy on open access.
The changes set out: what is classed as CRUK-funded intellectual property and how to handle changes of grant holder the requirements for patient data citations and data availability statements when publishing research our expectations for how you should handle, share and classify data in the research we fund. |
|
|---|
|
|---|
|
|
| | | Online 4:00 PM 26 April 2023 |
|
|---|
|
|---|
| | | Glasgow, UK 27 April 2023 |
|
|---|
|
|---|
| | | Online 12:00 PM 09 May 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 05 July 2023 |
|
|---|
|
|---|
| | | London, UK 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
